RichardGordonWeleberMD
Ophthalmology • Portland, ORRetinal Disease
Professor, Ophthalmology, Oregon Health and Science University School of Medicine
Dr. Weleber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-8311- Is this information wrong?
Education & Training
University of ColoradoFellowship, Medical Genetics and Genomics, 1975 - 1977
Oregon Health & Science UniversityResidency, Ophthalmology, 1971 - 1975- Oregon Health Science University HospitalFellowship, Clinical Biochemical Genetics, 1971 - 1972
- Oregon Health & Science UniversityFellowship, Medical Genetics and Genomics, 1971 - 1972
University of Vermont Medical CenterInternship, Transitional Year, 1967 - 1968
Oregon Health and Science University School of MedicineClass of 1967
Certifications & Licensure
OR State Medical License 1972 - 2023
CO State Medical License 1975 - 1977- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
- Fellow American College of Medical Genetics, 1993
- Diplomate American Board of Medical Genetids, 1981
- Join now to see all
Clinical Trials
- Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration Start of enrollment: 2011 Jun 08
- Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B Start of enrollment: 2012 Mar 26
- Clinical and Genetic Characterization of Individuals With Achromatopsia Start of enrollment: 2013 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsImproved Rod Sensitivity as Assessed by Two-Color Dark-Adapted Perimetry in Patients With RPE65-Related Retinopathy Treated With Voretigene Neparvovec-rzyl.Cristy A Ku, Austin D Igelman, Samuel J Huang, Huber Vasconcelos, Mariana Matioli da Palma, Steven T Bailey, Andreas K Lauer, Richard G Weleber, Paul Yang, Mark E Pennesi> ;Translational Vision Science & Technology. 2023 Apr 3
- 16 citationsThree-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinica...Maria A Parker, Laura R Erker, Isabelle Audo, Dongseok Choi, Saddek Mohand-Said, Kastytis Sestakauskas, Patrick Benoit, Terence Appelqvist, Melissa Krahmer, Caroline S...> ;American Journal of Ophthalmology. 2022 Aug 1
- 8 citationsComprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia.Solaki, M., Baumann, B., Reuter, P., Andreasson, S., Audo, I., Ayuso, C., Balousha, G., Benedicenti, F., Birch, D., Bitoun, P., Blain, D., Bocquet, B., Branham, K., Ca...> ;Human Mutation. 2022 Jul 1
- Join now to see all
Journal Articles
- Strategies for Treating Inherited Retinal Degeneration with Large Genes That Are Not Amenable to Adeno-Associated Virus–Based Gene Replacement TherapyMark E Pennesi, Richard G Weleber, JAMA Ophthalmology
- Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients with Autosomal Dominant Retinitis PigmentosaDavid G Birch, Michael P Teske, Richard G Weleber, Robert Lindblad, Byron L Lam, Judith Warner, Gary Edd Fish, Neal L Sklaver, Mark E Pennesi, John Heckenlively, Paul ..., JAMA
Press Mentions
In Surprise Result, Gene Therapy Reverses Blinding Eye DiseaseMarch 15th, 2018
New Study Shows Children Benefited Most from Gene Therapy for LCA, a Rare Eye DiseaseApril 15th, 2016
Professional Memberships
- Fellow
Hospital Affiliations
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
